Key facts
- This page summarizes John Thomas's Form 4 filing for GENELUX Corp (GNLX).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 07 Jun 2024, 21:45.
John Thomas - 29 May 2024 Form 4 Insider Report for GENELUX Corp (GNLX)
- Reporting relationship
- Director
- Issuer ticker
- GNLX
- Reported as of
- 29 May 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 07 Jun 2024, 21:45:16 UTC
- Prior SEC filing
- 14 Dec 2023
- Next SEC filing
- 31 Dec 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Thomas Zindrick, J.D., Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
John Thomas filed Form 4 for GENELUX Corp (GNLX) on 07 Jun 2024.
Change
- Previous filing in this sequence was filed on 14 Dec 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
GNLX
transaction
Common Stock
Purchase
- Transaction value
- Shares
- +2,500
- Change %
- +0.54%
- Price
- Shares after
- 465,960
- Date
- 29 May 2024
- Ownership
- Direct
- Footnotes
- F1, F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
GNLX
transaction
Derivative
Common Stock Warrant (Right to Buy)
Purchase
- Transaction value
- Shares
- +2,500
- Change %
- Price
- Shares after
- 2,500
- Date
- 29 May 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 2,500
- Exercise price
- $5.25
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
The Reporting Person's purchase reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934 with the Reporting Person's sale of common stock on December 13, 2023. The Reporting Person has agreed to pay to the Issuer the profit realized in connection with the short-swing transaction, less transaction costs.
Footnote F2
The reported securities consist of shares of common stock sold together with accompanying warrants to purchase common stock. The combined price of each share of common stock offered together with one warrant was $4.00.